• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

小 RNA 作为鉴别前列腺良恶性疾病的生物标志物:是否可以替代经直肠前列腺穿刺活检?

Small RNAs as biomarkers to differentiate benign and malign prostate diseases: An alternative for transrectal punch biopsy of the prostate?

机构信息

Division of Functional Genomics, Chair for Biochemistry and Molecular Medicine, Witten/Herdecke University, Witten, Germany.

Centre for Biomedical Education and Research (ZBAF), Witten/Herdecke University, Witten, Germany.

出版信息

PLoS One. 2021 Mar 24;16(3):e0247930. doi: 10.1371/journal.pone.0247930. eCollection 2021.

DOI:10.1371/journal.pone.0247930
PMID:33760831
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7990312/
Abstract

Prostate cancer (PCa) is the most common cancer and the third most frequent cause of male cancer death in Germany. MicroRNAs (miRNA) appear to be involved in the development and progression of PCa. A diagnostic differentiation from benign prostate hyperplasia (BPH) is often only possible through transrectal punch biopsy. This procedure is described as painful and carries risks. It was investigated whether urinary miRNAs can be used as biomarkers to differentiate the prostate diseases above. Therefore urine samples from urological patients with BPH (25) or PCa (28) were analysed using Next-Generation Sequencing to detect the expression profile of total and exosomal miRNA/piRNA. 79 miRNAs and 5 piwi-interacting RNAs (piRNAs) were significantly differentially expressed (adjusted p-value < 0.05 and log2-Fc > 1 or < -1). Of these, 6 miRNAs and 2 piRNAs could be statistically validated (AUC on test cohort > = 0.7). In addition, machine-learning algorithms were used to identify a panel of 22 additional miRNAs, whose interaction makes it possible to differentiate the groups as well. There are promising individual candidates for potential use as biomarkers in prostate cancer. The innovative approach of applying machine learning methods to this kind of data could lead to further small RNAs coming into scientific focus, which have so far been neglected.

摘要

前列腺癌(PCa)是德国最常见的癌症和男性癌症死亡的第三大常见原因。 microRNAs(miRNA)似乎参与了 PCa 的发展和进展。从良性前列腺增生(BPH)中进行诊断区分通常只能通过经直肠穿刺活检来完成。该过程被描述为疼痛且具有风险。研究人员调查了尿液中的 miRNA 是否可作为生物标志物来区分上述前列腺疾病。因此,使用下一代测序分析了来自患有 BPH(25 个)或 PCa(28 个)的泌尿科患者的尿液样本,以检测总 miRNA/piRNA 和外泌体 miRNA/piRNA 的表达谱。 79 个 miRNA 和 5 个 piwi 相互作用 RNA(piRNA)的表达水平存在显著差异(调整后的 p 值<0.05,log2-FC > 1 或 <-1)。其中,6 个 miRNA 和 2 个 piRNA 可以通过统计学验证(在测试队列中 AUC>=0.7)。此外,还使用机器学习算法来识别 22 个额外 miRNA 的组合,其相互作用也可以区分这些组。有一些有前途的个体候选物可作为前列腺癌的潜在生物标志物。应用机器学习方法来处理这种数据的创新方法可能会导致更多的小 RNA 受到科学界的关注,而这些小 RNA 迄今为止一直被忽视。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f58/7990312/59123e960615/pone.0247930.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f58/7990312/d334e5243ea5/pone.0247930.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f58/7990312/0c0dddce3a0c/pone.0247930.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f58/7990312/f3ec4bdaf446/pone.0247930.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f58/7990312/350e52865453/pone.0247930.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f58/7990312/a3ad1ca561ba/pone.0247930.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f58/7990312/b5e7ecd96f60/pone.0247930.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f58/7990312/59123e960615/pone.0247930.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f58/7990312/d334e5243ea5/pone.0247930.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f58/7990312/0c0dddce3a0c/pone.0247930.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f58/7990312/f3ec4bdaf446/pone.0247930.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f58/7990312/350e52865453/pone.0247930.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f58/7990312/a3ad1ca561ba/pone.0247930.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f58/7990312/b5e7ecd96f60/pone.0247930.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f58/7990312/59123e960615/pone.0247930.g007.jpg

相似文献

1
Small RNAs as biomarkers to differentiate benign and malign prostate diseases: An alternative for transrectal punch biopsy of the prostate?小 RNA 作为鉴别前列腺良恶性疾病的生物标志物:是否可以替代经直肠前列腺穿刺活检?
PLoS One. 2021 Mar 24;16(3):e0247930. doi: 10.1371/journal.pone.0247930. eCollection 2021.
2
Candidate diagnostic miRNAs that can detect cancer in prostate biopsy.可在前列腺活检中检测癌症的候选诊断性微小RNA。
Prostate. 2018 Feb;78(3):178-185. doi: 10.1002/pros.23427. Epub 2017 Dec 11.
3
Semen miRNAs Contained in Exosomes as Non-Invasive Biomarkers for Prostate Cancer Diagnosis.外泌体中的精子 miRNA 作为前列腺癌诊断的非侵入性生物标志物。
Sci Rep. 2019 Sep 24;9(1):13772. doi: 10.1038/s41598-019-50172-6.
4
MiR-145 detection in urinary extracellular vesicles increase diagnostic efficiency of prostate cancer based on hydrostatic filtration dialysis method.基于静水压过滤透析法检测尿液细胞外囊泡中的MiR-145可提高前列腺癌的诊断效率。
Prostate. 2017 Jul;77(10):1167-1175. doi: 10.1002/pros.23376. Epub 2017 Jun 15.
5
Extracellular RNAs from Whole Urine to Distinguish Prostate Cancer from Benign Prostatic Hyperplasia.全尿外泌体 RNA 区分前列腺癌与前列腺增生。
Int J Mol Sci. 2024 Sep 19;25(18):10079. doi: 10.3390/ijms251810079.
6
Challenges in Cancer Biomarker Discovery Exemplified by the Identification of Diagnostic MicroRNAs in Prostate Tissues.癌症生物标志物发现的挑战,以前列腺组织中诊断 microRNAs 的鉴定为例。
Biomed Res Int. 2020 May 5;2020:9086829. doi: 10.1155/2020/9086829. eCollection 2020.
7
miRNA-21 as High Potential Prostate Cancer Biomarker in Prostate Cancer Patients in Indonesia.miRNA-21 作为印度尼西亚前列腺癌患者的高潜力前列腺癌生物标志物。
Asian Pac J Cancer Prev. 2023 Mar 1;24(3):1095-1099. doi: 10.31557/APJCP.2023.24.3.1095.
8
Exosomes from bulk and stem cells from human prostate cancer have a differential microRNA content that contributes cooperatively over local and pre-metastatic niche.来自人类前列腺癌的大量细胞和干细胞的外泌体具有不同的微小RNA含量,这些微小RNA在局部和转移前生态位中协同发挥作用。
Oncotarget. 2016 Jan 26;7(4):3993-4008. doi: 10.18632/oncotarget.6540.
9
Detection of miRNAs in urine of prostate cancer patients.前列腺癌患者尿液中微小RNA的检测
Medicina (Kaunas). 2016;52(2):116-24. doi: 10.1016/j.medici.2016.02.007. Epub 2016 Mar 11.
10
Combination of Urinary MiR-501 and MiR-335 With Current Clinical Diagnostic Parameters as Potential Predictive Factors of Prostate Biopsy Outcome.尿 miR-501 和 miR-335 联合当前临床诊断参数作为前列腺活检结果的潜在预测因子。
Cancer Genomics Proteomics. 2023 May-Jun;20(3):308-316. doi: 10.21873/cgp.20383.

引用本文的文献

1
Exosomal Liquid Biopsy in Prostate Cancer: A Systematic Review of Biomarkers for Diagnosis, Prognosis, and Treatment Response.前列腺癌中的外泌体液体活检:诊断、预后和治疗反应生物标志物的系统评价
Int J Mol Sci. 2025 Jan 18;26(2):802. doi: 10.3390/ijms26020802.
2
Influence of aging and maternal protein restriction on PIWI-interacting RNA expression in the offspring rat ventral prostate.衰老和母体蛋白质限制对后代大鼠腹侧前列腺中PIWI相互作用RNA表达的影响。
Sci Rep. 2024 Dec 5;14(1):30372. doi: 10.1038/s41598-024-77901-w.
3
Role of non-coding RNA in lineage plasticity of prostate cancer.

本文引用的文献

1
Updates on Grading and Staging of Prostate Cancer.前列腺癌分级和分期的最新进展
Surg Pathol Clin. 2018 Dec;11(4):759-774. doi: 10.1016/j.path.2018.07.003.
2
miRBase: from microRNA sequences to function.miRBase:从 microRNA 序列到功能。
Nucleic Acids Res. 2019 Jan 8;47(D1):D155-D162. doi: 10.1093/nar/gky1141.
3
piRBase: a comprehensive database of piRNA sequences.piRBase:一个 piRNA 序列的综合数据库。
非编码RNA在前列腺癌谱系可塑性中的作用。
Cancer Gene Ther. 2025 Jan;32(1):1-10. doi: 10.1038/s41417-024-00834-z. Epub 2024 Nov 4.
4
Urinary miRNAs: Technical Updates.尿液微小RNA:技术更新
Microrna. 2024;13(2):110-123. doi: 10.2174/0122115366305985240502094814.
5
Exploring Optimal Biomarker Sources: A Comparative Analysis of Exosomes and Whole Plasma in Fasting and Non-Fasting Conditions for Liquid Biopsy Applications.探索最佳生物标志物来源:禁食和非禁食条件下用于液体活检应用的外泌体和全血浆的比较分析。
Int J Mol Sci. 2023 Dec 27;25(1):371. doi: 10.3390/ijms25010371.
6
The burgeoning importance of PIWI-interacting RNAs in cancer progression.PIWI 相互作用 RNA 在癌症进展中的重要性日益凸显。
Sci China Life Sci. 2024 Apr;67(4):653-662. doi: 10.1007/s11427-023-2491-7. Epub 2023 Dec 29.
7
The potential of piR-823 as a diagnostic biomarker in oncology: A systematic review.piR-823 作为肿瘤学诊断生物标志物的潜力:系统评价。
PLoS One. 2023 Dec 7;18(12):e0294685. doi: 10.1371/journal.pone.0294685. eCollection 2023.
8
Urinary MicroRNAs as Biomarkers of Urological Cancers: A Systematic Review.尿 MicroRNAs 作为泌尿系统癌症的生物标志物:系统评价。
Int J Mol Sci. 2023 Jun 29;24(13):10846. doi: 10.3390/ijms241310846.
9
Prostate Cancer-Associated miRNAs in Saliva: First Steps to an Easily Accessible and Reliable Screening Tool.唾液中的前列腺癌相关 miRNA:迈向易于获取和可靠的筛查工具的第一步。
Biomolecules. 2022 Sep 24;12(10):1366. doi: 10.3390/biom12101366.
10
Overview of MicroRNAs as Diagnostic and Prognostic Biomarkers for High-Incidence Cancers in 2021.2021 年高发性癌症的 microRNAs 作为诊断和预后生物标志物概述。
Int J Mol Sci. 2022 Sep 27;23(19):11389. doi: 10.3390/ijms231911389.
Nucleic Acids Res. 2019 Jan 8;47(D1):D175-D180. doi: 10.1093/nar/gky1043.
4
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
5
Exosomal microRNA profiling to identify hypoxia-related biomarkers in prostate cancer.外泌体微小RNA谱分析以鉴定前列腺癌中与缺氧相关的生物标志物。
Oncotarget. 2018 Feb 17;9(17):13894-13910. doi: 10.18632/oncotarget.24532. eCollection 2018 Mar 2.
6
The microRNA-15a-PAI-2 axis in cholangiocarcinoma-associated fibroblasts promotes migration of cancer cells.miRNA-15a-PAI-2 轴在胆管癌相关成纤维细胞中促进癌细胞迁移。
Mol Cancer. 2018 Jan 18;17(1):10. doi: 10.1186/s12943-018-0760-x.
7
EZH2 alteration driven by microRNA-524-5p and microRNA-324-5p promotes cell proliferation and temozolomide resistance in glioma.由微小RNA-524-5p和微小RNA-324-5p驱动的EZH2改变促进胶质瘤细胞增殖和对替莫唑胺的耐药性。
Oncotarget. 2017 Oct 24;8(56):96239-96248. doi: 10.18632/oncotarget.21996. eCollection 2017 Nov 10.
8
BioInfra.Prot: A comprehensive proteomics workflow including data standardization, protein inference, expression analysis and data publication.BioInfra.Prot:一个全面的蛋白质组学工作流程,包括数据标准化、蛋白质推断、表达分析和数据发布。
J Biotechnol. 2017 Nov 10;261:116-125. doi: 10.1016/j.jbiotec.2017.06.005. Epub 2017 Jun 9.
9
MiR-150 promotes cellular metastasis in non-small cell lung cancer by targeting FOXO4.miR-150 通过靶向 FOXO4 促进非小细胞肺癌细胞转移。
Sci Rep. 2016 Dec 15;6:39001. doi: 10.1038/srep39001.
10
MicroRNA expression and function in prostate cancer: a review of current knowledge and opportunities for discovery.微小RNA在前列腺癌中的表达与功能:当前知识及发现机遇综述
Asian J Androl. 2016 Jul-Aug;18(4):559-67. doi: 10.4103/1008-682X.177839.